The aim of neoadjuvant chemotherapy is to eliminate active cancer cells — producing a complete response — before surgery. (sciencedaily.com)
«We found that very few women with HER2 - and hormone receptor - positive breast cancer with a PIK3CA mutation experienced a pathologic complete response after receiving neoadjuvant therapy. (sciencedaily.com)
Kuang has teamed up with the Children's Specialty Center of Nevada and Nevada Imaging Centers to develop an earlier, non-invasive method for predicting success or failure of neoadjuvant chemotherapy. (unlv.edu)